Angiogenesis Inhibition
Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and...
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Electronic |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2010.
|
| Series: | Recent Results in Cancer Research,
180 |
| Subjects: | |
| Online Access: | https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-540-78281-0 |
Table of Contents:
- Introduction. Angiopoietins
- HIF-1a and cancer therapy
- Chemokines
- Platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy
- Vascular integrins: therapeutic and imaging targets of tumor angiogenesis. PDGF and vessel maturation
- Lymphangiogenesis in cancer: current perspectives
- Therapeutic compounds in clinical studies of Phase III trials and beyond
- Metronomic chemotherapy <U+0013> principles and lessons learned from applications in the treatment of metastatic prostate cancer
- Targeting inflammatory cells to improve anti-VEGF therapies in oncology
- Antibody-based vascular tumor targeting. Caveolae and cancer.